Literature DB >> 17652801

Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma.

L Vieira Neto1, G F Taboada, L L Corrêa, J Polo, A F Nascimento, L Chimelli, K Rumilla, M R Gadelha.   

Abstract

Ectopic growth hormone-releasing hormone (GHRH)-secreting tumors are rare and cause acromegaly with somatotroph hyperplasia. We report a case of acromegaly secondary to GHRH secretion by an incidentally discovered pheochromocytoma in a normotensive patient. A 23-year-old man presented with signs and symptoms of acromegaly. Laboratory evaluation confirmed the diagnosis and magnetic resonance imaging (MRI) revealed a sellar mass which was thought to be a macroadenoma and surgically resected. The patient was not cured and medical treatment was indicated. An abdominal ultrasound performed before initiation of medical treatment showed a solid/cystic lesion superiorly to the right kidney. An abdominal MRI confirmed an adrenal tumor. Hormonal workup of the adrenal incidentaloma revealed elevated urinary catecholamine and total metanephrines findings strongly suggestive of a pheochromocytoma. Acromegaly was then suspected to be due to ectopic secretion of GHRH by the tumor. Patient underwent surgical resection and histopathologic examination confirmed a pheochromocytoma which stained positively for GHRH. Also, review of the pituitary specimen confirmed somatotrophic hyperplasia. Genetic analysis of the ret proto-oncogene showed no mutation. Pituitary MRI was repeated 10 months after pheochromocytoma resection and revealed a slightly enlarged pituitary and partial empty sella. The diagnosis of acromegaly caused by ectopic production of GHRH is a challenging task. A careful histopathological examination of the surgically excised pituitary tissue has a key role to arouse the suspicion and guide the investigation of a secondary cause of acromegaly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652801     DOI: 10.1007/s12022-007-0006-8

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  42 in total

1.  PHEOCHROMOCYTOMA WITHOUT HYPERTENSION. REPORT OF A PATIENT WITH ACROMEGALY.

Authors:  M T KAHN; D A MULLON
Journal:  JAMA       Date:  1964-04-06       Impact factor: 56.272

2.  PITUITARY ADENOMAS: A FOLLOW-UP STUDY OF THE CUSHING SERIES.

Authors:  W J GERMAN; S FLANIGAN
Journal:  Clin Neurosurg       Date:  1964

3.  Ectopic acromegaly: localization of the pituitary growth hormone-releasing hormone producing tumor by In-111 pentetreotide scintigraphy and report of two cases.

Authors:  Olivier Morel; Philippe Giraud; Marie-Odile Bernier; Jean-Jacques Le Jeune; Vincent Rohmer; Pierre Jallet
Journal:  Clin Nucl Med       Date:  2004-12       Impact factor: 7.794

4.  Bilateral recurrent phaeochromocytoma associated with a growth hormone-secreting pituitary tumour.

Authors:  B T Teh; J Hansen; P J Svensson; L Hartley
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

Review 5.  Etiologic aspects and management of acromegaly.

Authors:  Giselle F Taboada; Flávia R van Haute; Lívia L Corrêa; Alessandra F Casini; Mônica R Gadelha
Journal:  Arq Bras Endocrinol Metabol       Date:  2006-01-23

6.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

Authors:  S L Asa; B W Scheithauer; J M Bilbao; E Horvath; N Ryan; K Kovacs; R V Randall; E R Laws; W Singer; J A Linfoot
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

7.  Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.

Authors:  M L Vance; D L Kaiser; W S Evans; R Furlanetto; W Vale; J Rivier; M O Thorner
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

8.  Acromegaly, hyperparathyroidism, and pheochromocytoma in the same patient. A multiple endocrine disorder.

Authors:  J H Myers; J J Eversman
Journal:  Arch Intern Med       Date:  1981-10

Review 9.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.

Authors:  T Sano; S L Asa; K Kovacs
Journal:  Endocr Rev       Date:  1988-08       Impact factor: 19.871

10.  Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features.

Authors:  Y Shintani; K Yoshimoto; H Horie; T Sano; Y Kanesaki; E Hosoi; Y Yokogoshi; H Bando; H Iwahana; S Kannuki
Journal:  Endocr J       Date:  1995-06       Impact factor: 2.349

View more
  11 in total

Review 1.  [Ectopia of the adrenal].

Authors:  W Saeger
Journal:  Pathologe       Date:  2018-09       Impact factor: 1.011

2.  Ectopic hormone-secreting pheochromocytoma: a francophone observational study.

Authors:  James Kirkby-Bott; Laurent Brunaud; Muriel Mathonet; Etienne Hamoir; Jean-Louis Kraimps; Christophe Trésallet; Laurence Amar; Alexandre Rault; Jean-Francois Henry; Bruno Carnaille
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

3.  Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy.

Authors:  Peter W Butler; Craig S Cochran; Maria J Merino; Dao M Nguyen; David S Schrump; Phillip Gorden
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 4.  Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review.

Authors:  Iga Zendran; Gabriela Gut; Marcin Kałużny; Katarzyna Zawadzka; Marek Bolanowski
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 5.  Current diagnosis of acromegaly.

Authors:  Rocio A Cordero; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 6.  Ectopic acromegaly due to growth hormone releasing hormone.

Authors:  Ali A Ghazi; Alireza Amirbaigloo; Azizollah Abbasi Dezfooli; Navid Saadat; Siavash Ghazi; Marina Pourafkari; Farrokh Tirgari; Dheepti Dhall; Serguei Bannykh; Shlomo Melmed; Odelia Cooper
Journal:  Endocrine       Date:  2012-09-15       Impact factor: 3.633

7.  Identification of a TMEM127 variant in a patient with paraganglioma and acromegaly.

Authors:  Beryl Stütz; Marta Korbonits; Karl Kothbauer; Werner Müller; Stefan Fischli
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-09-23

8.  Phaeochromocytoma and Acromegaly: a unifying diagnosis.

Authors:  C Mumby; J R E Davis; J Trouillas; C E Higham
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-05-01

9.  GHRH secretion from a pancreatic neuroendocrine tumor causing gigantism in a patient with MEN1.

Authors:  Vinaya Srirangam Nadhamuni; Donato Iacovazzo; Jane Evanson; Anju Sahdev; Jacqueline Trouillas; Lorraine McAndrew; Tom R Kurzawinski; David Bryant; Khalid Hussain; Satya Bhattacharya; Márta Korbonits
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-06-01

Review 10.  Genetics of Acromegaly and Gigantism.

Authors:  Anna Bogusławska; Márta Korbonits
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.